EPIS® Právní systém | Plné znění

XXŘ&Xxxxxx;XXX&Xxxxxx; KOMISE (XX) 2015/1221

xx xxx 24. čxxxxxxx 2015,

kterým xx xxx &xxxxxx;čxxx xřxxxůxxxxx&xxxxxx; xěxxxxxxxxxxxxx&xxxxxx;xx pokroku xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (ES) č.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx a směsí

(Xxxx x x&xxxxxx;xxxxxx xxx XXX)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx na Xxxxxxx x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Xxxxxxx&xxxxxx; xxxx,

x&xxxx;xxxxxxx xx nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx a Rady (XX) č.&xxxx;1272/2008 xx xxx 16. xxxxxxxx 2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx a směsí, x&xxxx;xxěxě x&xxxx;xxx&xxxxxx;xx&xxxxxx; xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě nařízení (XX) č.&xxxx;1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx xx čx.&xxxx;37 xxxx.&xxxx;5 xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx;,

xxxxxxxx x&xxxx;xěxxx xůxxxůx:

(1)

Č&xxxxxx;xx 3 přílohy XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 obsahuje dva xxxxxxx xxxxxxxxxxxx&xxxxxx;xx klasifikací x&xxxx;xxxxčxx&xxxxxx; nebezpečných x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 je xxxxxx seznam xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; nebezpečných x&xxxxxx;xxx xx základě xxxx&xxxxxx;xx&xxxxxx; stanovených x&xxxx;č&xxxxxx;xxxxx 2 xž 5 xř&xxxxxx;xxxx X&xxxx;xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008. V tabulce 3.2 xx xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx látek na x&xxxxxx;xxxxě kritérií xxxxxxxx&xxxxxx;xx x&xxxx;xř&xxxxxx;xxxx XX xxěxxxxx Xxxx 67/548/XXX (2).

(2)

Xxxxxxx&xxxxxx; agentuře xxx xxxxxxx&xxxxxx; látky (XXXX) xxxx v souladu x&xxxx;čx&xxxxxx;xxxx&xxxx;37 xxř&xxxxxx;xxx&xxxxxx; (ES) č.&xxxx;1272/2008 xřxxxxžxxx x&xxxxxx;xxxx xx xxx&xxxxxx; xxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; klasifikace x&xxxx;xxxxčxx&xxxxxx; některých látek. Xx x&xxxxxx;xxxxě xxxxxxxxxx x&xxxx;xěxxx x&xxxxxx;xxxůx, xxxx&xxxxxx; xxxxx Výbor xxx xxxxxxx&xxxxxx;x&xxxxxx; rizik (RAC) xůxxx&xxxxxx;x&xxxxxx; x&xxxx;x&xxxxxx;xxx Xxxxxxx&xxxxxx; xxxxxxxx xxx xxxxxxx&xxxxxx; x&xxxxxx;xxx, xxxxž i připomínek x&xxxxxx;čxxxxěx&xxxxxx;xx xxxxx, je xxxxx&xxxxxx; xxěxxx xř&xxxxxx;xxxx XX xxxxxx&xxxxxx;xx nařízení xxx&xxxxxx;xx čx xxxxxxxxxxxx xxxxxxxxxxxx&xxxxxx; klasifikace a označení xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(3)

Xxxxx xxx x&xxxx;x&xxxxxx;xxx &xxxxx;xxxxxxxx dusičná &xxxxxx; %“ (č. ES: 231-714-2), jsou xxx&xxxxxx; x&xxxx;xxxxxxxxx nové xěxxxx&xxxxxx; &xxxxxx;xxxx pro xř&xxxxxx;xx xxxxxxxčxxxxx &xxxxx;xxxxx&xxxxxx; xxxxxxxx&xxxxx;, xxxx&xxxxxx; xxxxxčxx&xxxxxx;, žx xxxxxxxxxxx xxx tuto xř&xxxxxx;xx nebezpečnosti xxxxxxčxxxx&xxxxxx; xx stanovisku x&xxxxxx;xxxx XXX, xxž xx xxxx&xxxxxx;x&xxxxxx; xx xxxx&xxxxxx;&xxxxxx;xx &xxxxxx;xxx&xxxxxx;xx, xx xxxxxxxx x&xxxxxx;x přiměřená. Xxxx xř&xxxxxx;xx nebezpečnosti xx xxxxx xxxěxx být xxřxxxxx xx přílohy XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxxx x&xxxxxx;xxx XXX xxxxx&xxxxxx; stanovisko x&xxxx;xxx&xxxxxx;x xxxxxxxx&xxxxxx;x, xxx&xxxxxx;xxx x&xxxxxx;xxxxx xxxxxx&xxxxxx; třídy xxxxxxxčxxxxx xxxxžxx&xxxxxx; x&xxxx;xxxxxxxx&xxxxxx;x xxxxxxxxxx x&xxxxxx;xxxx XXX xx zařazeny být xěxx.

(4)

Xxxxx jde x&xxxx;x&xxxxxx;xxx &xxxxx;xxxxx, dodecyl-, rozvětvený“ (č.&xxxx;XX: 310-154-3), výbor XXX xxxxxxxx&xxxxxx;x&xxxxxx; nové xxxxxxxxxx xxxxxxě xxxxxxxxx&xxxxxx;xx xxxxxxxxxčx&xxxxxx;xx xxxxxů, které xx xxxžxx&xxxxxx; pro xř&xxxxxx;xx xxxxxxxčxxxxx „toxický xxx reprodukci“. Tato xř&xxxxxx;xx xxxxxxxčxxxxx xx xxxxx xxxěxx x&xxxxxx;x xxřxxxxx do xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, dokud toto xxxxxxxxxx xxxxxx xxxxxčxxx.

(5)

Xxxxžxx&xxxxxx;x&xxxxxx; xxx&xxxxxx;xx harmonizovaných klasifikací xx nemělo x&xxxxxx;x xxžxxxx&xxxxxx;xx xxxxx, jelikož xxxxxxxxx&xxxxxx; xxxxx xxxřxxxxxx xxčxx&xxxxxx; čxxxx&xxxxxx; xxxxx&xxxxxx; xx to, aby xřxxxůxxxxxx označování x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx a směsí novým xxxxxxxxxx&xxxxxx;x x&xxxx;xxxxxxx xx&xxxxxx;xxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Xxxxě xxxx xxxxx xxxřxxxxxx určité čxxxx&xxxxxx; období i na xx, xxx xxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxxx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; z nových xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;xx xxxx xxxxxxxxxxx&xxxxxx;, xxxxxxxx&xxxxxx; xxxx xxxxxx&xxxxxx; xxx xxxxxxxxxx, xxxxxxxx&xxxxxx; 1&xxxx;X x&xxxx;1X (tabulka 3.1) x&xxxx;xxxxxxxx&xxxxxx; 1 x&xxxx;2 (xxxxxxx&xxxx;3.2) xxxx xxxx xxxxxx xxxxxx&xxxxxx; xxx xxxx&xxxxxx; xxxxxxxxx x&xxxx;xxžxxxx&xxxxxx; vyvolat dlouhodobé xxxř&xxxxxx;xxxx&xxxxxx; &xxxxxx;čxxxx ve xxxx&xxxxxx;x xxxxxřxx&xxxxxx;, xxxx&xxxxxx;xx xxx xxxxxxxxxx xxxxxxxx&xxxxxx; x&xxxx;čx&xxxxxx;xxx&xxxx;23 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx a Rady (ES) č.&xxxx;1907/2006 (3).

(6)

X&xxxx;xxxxxxx s přechodnými ustanoveními xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, xxxx&xxxxxx; umožňují dobrovolně xxxž&xxxxxx;x xxx&xxxxxx; xxxxxxxxx&xxxxxx; xř&xxxxxx;xx, xx xxxxxxxxx&xxxxxx; xěxx x&xxxxxx;x možnost xxxž&xxxxxx;x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xxxxxxxxxě xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; xřxx xxůxxx x&xxxx;xxxxžxx&xxxxxx; xxxxxxx.

(7)	Xxxxřxx&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x jsou x&xxxx;xxxxxxx xx xxxxxxxxxxx x&xxxxxx;xxxx xř&xxxxxx;xxx&xxxxxx;xx xxxxx čx&xxxxxx;xxx&xxxx;133 nařízení (XX) č.&xxxx;1907/2006,

XŘXXXXX TOTO NAŘÍZENÍ:

Čx&xxxxxx;xxx&xxxx;1

Xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008 se xěx&xxxxxx; v souladu x&xxxx;xř&xxxxxx;xxxxx xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

Čx&xxxxxx;xxx&xxxx;2

Xxxxxxxě xx čl. 3 xxxx.&xxxx;2 lze harmonizované xxxxxxxxxxx xxxxxxxx&xxxxxx; x&xxxx;xř&xxxxxx;xxxx xxxxxx xxř&xxxxxx;xxx&xxxxxx; xxxž&xxxxxx;x xřxx datem xxxxxx&xxxxxx;x x&xxxx;čx.&xxxx;3 odst. 2.

Čx&xxxxxx;xxx&xxxx;3

1.&xxxx;&xxxx;&xxxx;Xxxx nařízení vstupuje x&xxxx;xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x xxxx xx vyhlášení v Úředním xěxxx&xxxxxx;xx Evropské xxxx.

2.&xxxx;&xxxx;&xxxx;Čx&xxxxxx;xxx 1 se xxx x&xxxxxx;xxx x&xxxx;xxěxx xxxžxxx xxx xxx 1. xxxxx 2017.

Xxxx nařízení xx xxxxxxx v celém xxxxxxx x&xxxx;xxxxx použitelné xx xxxxx členských státech.

V Bruselu xxx 24. xxxxxxxx 2015.

Xx Komisi

předseda

Jean-Claude XXXXXXX

(1) Úř. xxxx. X&xxxx;353, 31.12.2008, s. 1.

(2)&xxxx;&xxxx;Xxxxxxxx Rady 67/548/EHS xx xxx 27. xxxxxx 1967 x xxxxxxxxxx právních x xxxxxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxxxxxx, xxxxxx x xxxxxxxxxx nebezpečných xxxxx (Xx. xxxx.&xxxx;196, 16.8.1967, x.&xxxx;1).

(3) Nařízení Xxxxxxxxxx xxxxxxxxxx x Rady (XX) x.&xxxx;1907/2006 ze xxx 18. prosince 2006 x xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx x omezování xxxxxxxxxx látek, x xxxxxxx Xxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxx, x xxxxx xxxxxxxx 1999/45/XX x x xxxxxxx nařízení Xxxx (XXX) x.&xxxx;793/93, xxxxxxxx Xxxxxx (ES) x.&xxxx;1488/94, xxxxxxxx Rady 76/769/XXX x xxxxxxx Xxxxxx 91/155/XXX, 93/67/XXX, 93/105/XX x 2000/21/ESÚř. věst. X&xxxx;396, 30.12.2006, x.&xxxx;1.

XXXXXXX

Xxxx 3 přílohy XX nařízení (XX) x. 1272/2008 xx xxxx xxxxx:

Xxxxxxx 3.1 xx xxxx xxxxx:

Xxxxxxx xxxxxxxxxxxx xxxxxxxxx číslům 007-004-00-1, 015-003-00-2, 031-001-00-4, 050-008-00-3, 603-102-00-9, 603-197-00-7, 606-054-00-7, 607-197-00-8, 613-042-00-5, 613-057-00-7, 613-133-00-X x&xxxx;613-149-00-7 xx xxxxxxxxx xxxxxx xxxxxxxxxxxxxx položkami:

Indexové číslo	Mezinárodní xxxxxxxxxxxx chemických xxxxx	Xxxxx XX	Xxxxx XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx koncent. xxxxxx, multiplikační faktory	Pozn.
Indexové číslo	Mezinárodní xxxxxxxxxxxx chemických xxxxx	Xxxxx XX	Xxxxx XXX	Kódy xxxx x&xxxx;xxxxxxxxx nebezpečnosti	Kódy xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx a signálních xxxx	Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx	Xxxx doplň. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxxxxxxxx koncent. xxxxxx, multiplikační faktory	Pozn.
007-004-00-1	xxxxxxxx dusičná … %	231-714-2	7697-37-2	Ox. Xxx. 2 Skin Corr. 1&xxxx;X	X272 X314	XXX03 XXX05 Xxx	X272 X314	XXX071	Xxxx Xxxx. 1 A; X314: X ≥&xxxx;20 % Xxxx Xxxx. 1B; X314: 5 % ≤ X < 20 % Xx. Xxx. 2; X272: C ≥ 99 % Xx. Xxx. 3; X272: 99 % &xx; X ≥ 65 %	X
015-003-00-2	xxxxxx vápenatý; trikalcium xxxxxxxx	215-142-0	1305-99-3	Xxxxx-xxxxx. 1 Xxxxx Xxx. 2 Xxxxx Xxx. 3 Acute Xxx. 1 Xxx Dam. 1 Xxxxxxx Xxxxx 1	X260 X300 X311 X330 X318 X400	XXX02 XXX06 XXX05 XXX09 Xxx	X260 X300 X311 X330 X318 X400	XXX029 XXX032	X&xxxx;= 100
031-001-00-4	xxxxxxx xxxxx	215-114-8	1303-00-0	Xxxx. 1B Carc. 1X XXXX XX 1	H360F H350 H372 (xxxxxxx x&xxxx;xxxxxxxxxx xxxxxx)	XXX08 Xxx	X360X X350 X372 (xxxxxxx x&xxxx;xxxxxxxxxx xxxxxx)
050-008-00-3	xxxxxxxxxxxxxxxx xxxxxxxxxx, x&xxxx;xxxxxxxx tributylcíničitých xxxxxxxxx uvedených xxxxx x&xxxx;xxxx xxxxxxx	—	—	Xxxx. 1B Acute Xxx. 3 Acute Xxx. 4* XXXX XX 1 Xxxx Xxxxx. 2 Eye Xxxxx. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360XX X301 X312 X372** X315 X319 X400 X410	XXX08 XXX06 XXX09 Xxx	X360XX X301 X312 X372** X315 X319 X410		* XXXX XX 1; H372: X ≥&xxxx;1 % STOT RE 2; H373: 0,25 % ≤ C &xx;&xxxx;1 % Xxxx Xxxxx. 2; X315:X ≥&xxxx;1 % Xxx Xxxxx. 2; X319:X ≥&xxxx;1 % X&xxxx;= 10	X 1
603-102-00-9	1,2-xxxxxxxxxx	203-438-2	106-88-7	Xxxx. Xxx. 2 Xxxx. 2 Xxxxx Xxx. 4* Xxxxx Xxx. 4* Xxxxx Tox. 4* XXXX XX 3 Xxxx Xxxxx. 2 Xxx Xxxxx. 2	X225 X351 X302 X312 X332 X335 X315 X319	XXX02 XXX08 XXX07 Xxx	X225 X351 X302 X312 X332 X335 X315 X319
603-197-00-7	xxxxxxxxxxx (XXX); 1-(4-xxxxxxxxxx)-4,4-xxxxxxxx-3-(1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxx-3-xx	403-640-2	107534-96-3	Xxxx. 2 Xxxxx Xxx. 4 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X361x*** X302 X400 X410	XXX08 XXX07 XXX09 Xxx	X361x*** X302 X410		X&xxxx;= 1 X&xxxx;= 10
606-054-00-7	xxxxxxxxxxx (XXX); 5-xxxxxxxxxxx-1,2-xxxxxx-4-xx-α,α,α-xxxxxxxx-2-xxxxx-x-xxxxxxxxxx	—	141112-29-0	Xxxx. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X361x*** X400 X410	XXX08 XXX09 Xxx	X361x*** X410		X&xxxx;= 10 X&xxxx;= 100
607-197-00-8	xxxxxxxx xxxxxxxx	203-931-2	112-05-0	Xxxx Xxxxx. 2 Eye Xxxxx. 2 Aquatic Xxxxxxx 3	X315 X319 X412	XXX07 Xxx	X315 X319 X412
613-042-00-5	xxxxxxxx (XXX); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx	252-615-0	35554-44-0	Xxxx. 2 Xxxxx Tox. 3 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxxxx 1	H351 H301 H332 H318 H410	GHS08 GHS06 GHS05 GHS09 Dgr	H351 H301 H332 H318 H410		M = 10
613-057-00-7	xxxxxxxxx (XXX); 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx	216-474-9	1593-77-7	Xxxx. 2 XXXX XX 2 Xxxx Xxxx. 1X Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X361x X373 (játra) H314 H317 H400 H410	GHS08 GHS05 GHS07 GHS09 Dgr	H361d H373 (xxxxx) X314 X317 X410	XXX071	X&xxxx;= 1 X&xxxx;= 1
613-133-00-X	xxxxxxxxxx (XXX); 5-ethoxy-3-trichlormethyl-1,2,4-thiadiazol	219-991-8	2593-15-9	Carc. 2 Acute Xxx. 4 Skin Sens. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X302 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X302 X317 X410		X&xxxx;= 1 X&xxxx;= 1
613-149-00-7	xxxxxxxxx (ISO); 2-terc-butyl-5-[(4-terc-butylbenzyl)sulfanyl]-4-chlorpyridazin-3(2H)-on	405-700-3	96489-71-3	Acute Xxx. 3 Xxxxx Xxx. 3 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X331 X301 X400 X410	XXX06 XXX09 Xxx	X331 X301 X410		X&xxxx;= 1 000 M = 1&xxxx;000

Xxxxxxxxxxx xxxxxxx se xxxxxxxx v souladu x&xxxx;xxxxxxxxxxxx xxxxxxx stanovených v tabulce 3.1:

Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx koncent. xxxxxx, xxxxxxxxxxxxx xxxxxxx	Xxxx.
Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxx xxxx x&xxxx;xxxxxxxxx nebezpečnosti	Kódy xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx výstražných xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxxxxxxxx koncent. xxxxxx, xxxxxxxxxxxxx xxxxxxx	Xxxx.
019-003-00-3	xxxxxx-(X,X)-xxxx-2,4-xxxxxxx	246-376-1	24634-61-5	Xxx Xxxxx. 2	X319	XXX07 Xxx	X319
604-092-00-9	xxxxx, xxxxxxx-, rozvětvený [1]; fenol, 2-xxxxxxx-, xxxxxxxxxx; xxxxx, 3-xxxxxxx-, xxxxxxxxxx; xxxxx, 4-dodecyl-, xxxxxxxxxx; xxxxx, (xxxxxxxxxxxxx)xxxxxxxx&xxxx;[2]	310-154-3 [1]	121158-58-5 [1] 74499-35-7 [2]	Xxxx Xxxx. 1X Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X314 X400 X410	XXX05 XXX09 Xxx	X314 X410		X&xxxx;= 10 X&xxxx;= 10
606-148-00-8	xxxxxx (XXX); 2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx; [1] X-xxxxxx; (5S)-2-methyl-5-(prop-1-en-2-yl)cyklohex-2-en-1-on; [2] X-xxxxxx; (5X)-2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx [3]	202-759-5 [1] 218-827-2 [2] 229-352-5 [3]	99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3]	Xxxx Xxxx. 1	X317	XXX07 Xxx	X317
606-149-00-3	xxxxxxxxxx (ISO); 2-{2-xxxxx-4-(xxxxxxxxxxxxxx)-3-[(2,2,2-xxxxxxxxxxxxxx)xxxxxx]xxxxxxx}xxxxxxxxxx-1,3-xxxx	—	335104-84-2	Xxxx. 2 XXXX XX 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X361x X373 (xxx, xxxxxxx, xxxxx) X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X361x X373 (xxx, xxxxxxx, xxxxx) X317 X410		X&xxxx;= 100 M = 10
607-707-00-9	xxxxxxxxxx-X-xxxxx (XXX); ethyl-(2R)-2-{4-[(6-chlor-1,3-benzoxazol-2-yl)oxy]fenoxy}propanoát	—	71283-80-2	STOT RE 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X373 (ledviny) H317 H400 H410	GHS08 GHS07 GHS09 Wng	H373 (xxxxxxx) X317 X410		X&xxxx;= 1 X&xxxx;= 1
607-708-00-4	xxxxxxxx kyselina	204-677-5	124-07-2	Skin Xxxx. 1X Xxxxxxx Chronic 3	X314 X412	XXX05 Xxx	X314 X412
607-709-00-X	xxxxxxxx kyselina	206-376-4	334-48-5	Skin Xxxxx. 2 Xxx Irrit. 2 Xxxxxxx Xxxxxxx 3	H315 H319 H412	GHS07 Wng	H315 H319 H412
607-710-00-5	1,2-benzendikarboxylová xxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxx	271-093-5	68515-50-4	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX
607-711-00-0	xxxxxxxxxxxxx (XXX); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx	—	203313-25-1	Xxxx. 2 XXXX XX 3 Eye Xxxxx. 2 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X361xx X335 X319 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X361xx X335 X319 X317 X410		X&xxxx;= 1 M = 1
607-712-00-6	xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx	250-778-2	31717-87-0	Xxxx. 2 STOT XX 2 Xxxx Xxxx. 1X Xxxx Sens. 1&xxxx;X Xxxxxxx Xxxxxxx 1	X361x X373 (xxxxx) X314 X317 X410	XXX08 XXX05 XXX07 XXX09 Xxx	X361x X373 (xxxxx) X314 X317 X410	XXX071	X&xxxx;= 1
607-713-00-1	xxxxxxxxxxxx (XXX); xxxx-xxxxx-4-[({(X)-[(1,3-xxxxxxxx-5-xxxxxx-1X-xxxxxxx-4-xx)xxxxxxxx]xxxxx}xxx)xxxxxx]xxxxxxx	—	134098-61-6	Xxxxx Tox. 3 Acute Xxx. 2 Skin Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X301 X330 X317 X400 X410	XXX06 XXX09 Xxx	X301 X330 X317 X410		X&xxxx;= 100 X&xxxx;= 1&xxxx;000
607-714-00-7	xxxxxxxxxxxxxx-xxxxxx; xxxxxx-2-({[4-(xxxxxxxxxxxxx)-6-(2,2,2-xxxxxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxx}xxxxxxxxx)-3-xxxxxxxxxxxxx	—	126535-15-7	Xxxx. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H351 H400 H410	GHS08 GHS09 Wng	H351 H410		M = 100 M = 10
607-715-00-2	xxxxxxxxx (ISO); isopropyl-2-(4-methoxybifenyl-3-yl)hydrazinkarboxylát	442-820-5	149877-41-8	STOT XX 2 Xxxx Sens. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H373 H317 H400 H410	GHS08 GHS07 GHS09 Wng	H373 H317 H410		M = 1 X&xxxx;= 1
613-319-00-0	xxxxxxxx	206-019-2	288-32-4	Xxxx. 1X Xxxxx Tox. 4 Xxxx Corr. 1X	X360X X302 X314	XXX08 XXX07 XXX05 Xxx	X360X X302 X314
613-320-00-6	xxxxxxx (XXX); 3-cyklohexyl-6,7-dihydro-1H-cyklopenta[d]pyrimidin-2,4(3H,5H)-dion	218-499-0	2164-08-1	Carc. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X400 X410	XXX08 XXX09 Xxx	X351 X410		X&xxxx;= 10 X&xxxx;= 10
616-213-00-2	mandipropamid (XXX); 2-(4-xxxxxxxxxx)-X-{2-[3-xxxxxxx-4-(xxxx-2-xx-1-xxxxx)xxxxx]xxxxx}-2-(xxxx-2-xx-1-xxxxx)xxxxxxxx	—	374726-62-2	Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1 X&xxxx;= 1
616-214-00-8	xxxxxxxxx (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx	—	139528-85-1	Xxxx. 2 STOT XX 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H351 H373 (xxx, xxxxxxx) X400 X410	XXX08 XXX09 Xxx	X351 X373 (xxx, xxxxxxx) X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100
616-215-00-3	xxxxxxxxxxxx-X (XXX); 2-xxxxx-X-(2,4-xxxxxxxx-3-xxxxxxx)-X-[(2X)-1-xxxxxxxxxxxxx-2-xx]xxxxxxxx	—	163515-14-8	Xxxxx Tox. 4 Xxxx Xxxx. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H302 H317 H400 H410	GHS07 GHS09 Wng	H302 H317 H410		M = 10 X&xxxx;= 10
616-216-00-9	xxxxxxxxxx (ISO); X-(xxxxxxxxxxx)-4-(xxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx	—	158062-67-0	Xxxxx Xxx. 4	X302	XXX07 Xxx	X302
616-217-00-4	xxxxxxxxxxx (XXX); [methyl(oxo){1-[6-(trifluormethyl)-3-pyridyl]ethyl}-λ6-sulfanyliden]kyanamid	—	946578-00-3	Acute Xxx. 4 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H302 H400 H410	GHS07 GHS09 Wng	H302 H410		M = 1 X&xxxx;= 1

Xxxxxxx 3.2 se xxxx xxxxx:

Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx	Xxxxx ES	Číslo XXX	Xxxxxxxxxxx	Xxxxxxxx	Xxxxxxxxxxxx xxxxxx	Xxxxxxxx k přípravkům
007-004-00-1	kyselina xxxxxxx&xxxx;…&xxxx;%	231-714-2	7697-37-2	X; X8 X; R35	O; X X: 8-35 X: (1/2-)26-28- 36/37/39-45-63	X; R8: X ≥&xxxx;65 % X; X35: X ≥&xxxx;20 % X; X34: 5 % ≤ C < 20 %	X
015-003-00-2	xxxxxx xxxxxxxx; trikalcium xxxxxxxx	215-142-0	1305-99-3	X; X15/29 X+; X26/28 Xx; X21 X32 Xx; X38-41 X; R50	F; X+; X X: 15/29-21-26/28-32-38-41-50 X:(1/2-)26-28-30-36/37/39-43-45-60-61	X; X50: X ≥&xxxx;0,25 %
031-001-00-4	xxxxxxx xxxxx	215-114-8	1303-00-0	Xxxx. Xxx. 2; X60 Xxxx. Cat. 2; R45 T; X48/23	X X: 45-48/23-60 X: 45-53		X
050-008-00-3	xxxxxxxxxxxxxxxx xxxxxxxxxx, x&xxxx;xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxx x&xxxx;xxxx xxxxxxx	—	—	Xxxx. Xxx. 2; X60-61 X; X25-48/23/25 Xx; R21 Xi; X36/38 X; R50-53	T; N R: 21-25-36/38-48/23/25-50/53-60-61 X: 45-53-60-61	X; X25: X ≥&xxxx;2,5 % Xx; X22: 0,25 % ≤ C &xx;&xxxx;2,5 % Xx: R21: X ≥&xxxx;1 % X; X48/23/25: X ≥&xxxx;1 % Xn; X48/20/22: 0,25 % ≤ C &xx;&xxxx;1 % Xx; X36/38: C ≥&xxxx;1 % X; R50-53: X ≥&xxxx;2,5 % X; X51-53: 0,25 % ≤ X &xx;&xxxx;2,5 % X52-53: 0,025 % ≤ X &xx;&xxxx;0,25 %	X 1
603-102-00-9	1,2-xxxxxxxxxx	203-438-2	106-88-7	X; X11 Xxxx. Cat. 3; R40 Xn; X20/21/22 Xx; X36/37/38	X; Xn R: 11-20/21/22-36/37/38-40- X: (2-)9-16-29-36/37-46
603-197-00-7	xxxxxxxxxxx (XXX); 1-(4-chlorfenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol	403-640-2	107534-96-3	Repr. Xxx. 3; X63 Xx; X22 X; R50-53	Xn; N R: 22-50/53-63 X: (2-)22-36/37-60-61	X; X50-53: X ≥&xxxx;25 % N; X51-53: 2,5 % ≤ X < 25 % X52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %
606-054-00-7	xxxxxxxxxxx (XXX); 5-xxxxxxxxxxx-1,2-xxxxxx-4-xx-α, α,α-xxxxxxxx-2-xxxxx-x-xxxxxxxxxx	—	141112-29-0	Xxxx. Xxx. 3; X63 X; X50-53	Xx; X X: 50/53-63 X: (2-)36/37-60-61	X; X50-53: X ≥&xxxx;2,5 % X; X51-53: 0,25 % ≤ C &xx;&xxxx;2,5 % X52-53: 0,025 % ≤ X < 0,25 %
607-197-00-8	xxxxxxxx xxxxxxxx	203-931-2	112-05-0	Xx; R36/38 N; X51-53	Xx; X X: 36/38-51/53 S: (2-)46-61
613-042-00-5	xxxxxxxx (XXX); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx	252-615-0	35554-44-0	Xxxx. Xxx. 3; R40 Xn; X20/22 Xx; X41 X; X51-53	Xx; X X: 20/22-40-41-51/53 S: (2-)26-36/37/39-46-61
613-057-00-7	dodemorph (XXX); 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx	216-474-9	1593-77-7	Xxxx. Cat. 3; R63 C; R34 R43 N; X50-53	X; N R: 34-43-50/53-63 S: (1/2-)26-28-36/37/39-45-60-61	X; X34: C ≥&xxxx;10 % Xi; X36/37/38: 5 % ≤ X &xx;&xxxx;10 % X; X50-53: X ≥&xxxx;25 % X; X51-53: 2,5 % ≤ C &xx;&xxxx;25 % X52-53: 0,25 % ≤ C &xx;&xxxx;2,5 %
613-133-00-X	etridiazol (XXX); 5-xxxxxx-3-xxxxxxxxxxxxxx-1,2,4-xxxxxxxxxx	219-991-8	2593-15-9	Xxxx. Cat. 3; X40 Xx; X22 X43 X; R50-53	Xn; X X: 22-40-43-50/53 S: (2-)36/37-46-60-61	X; X50-53: C ≥&xxxx;25 % X; X51-53: 2,5 % ≤ X &xx;&xxxx;25 % X52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %
613-149-00-7	xxxxxxxxx (XXX); 2-xxxx-xxxxx-5-[(4-xxxx-xxxxxxxxxxx)xxxxxxxx]-4-xxxxxxxxxxxxxx-3(2X)-xx	405-700-3	96489-71-3	X; R23/25 N; X50-53	X; X X: 23/25-50/53 X: (1/2-)36/37-45-60-61	X; X50-53: X ≥&xxxx;0,025 % X; R51-53: 0,0025 % ≤ X &xx;&xxxx;0,025 % R52-53: 0,00025 % ≤ X &xx;&xxxx;0,0025 %

Následující xxxxxxx xx xxxxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 3.2:

Indexové xxxxx	Xxxxxxxxxxx xxxxxxxxxxxx chemických látek	Číslo XX	Xxxxx CAS	Klasifikace	Označení	Koncentrační limity	Poznámky x&xxxx;xxxxxxxxxx
019-003-00-3	xxxxxx-(X,X)-xxxx-2,4-xxxxxxx	246-376-1	24634-61-5	Xx; R36	Xi R: 36 S: (2-)25-46
604-092-00-9	xxxxx, xxxxxxx-, xxxxxxxxxx [1]; xxxxx, 2-xxxxxxx-, rozvětvený; fenol, 3-xxxxxxx-, xxxxxxxxxx; xxxxx, 4-xxxxxxx-, xxxxxxxxxx; xxxxx, (tetrapropenyl)deriváty [2]	310-154-3 [1]-[2]	121158-58-5 [1] 74499-35-7 [2]	C; X34 X; X50-53	X; X X: 34-50/53 S: (1/2-)26-36/37/39-45-61	X; X50-53: X ≥&xxxx;2,5 % X; X51-53: 0,25 % ≤ X &xx;&xxxx;2,5 % X52-53: 0,025 % ≤ X &xx;&xxxx;0,25 %
606-148-00-8	xxxxxx (XXX); 2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx; [1] D-karvon; (5S)-2-methyl-5-(prop-1-en-2-yl)cyklohex-2-en-1-on; [2] X-xxxxxx; (5X)-2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx [3]	202-759-5 [1] 218-827-2 [2] 229-352-5 [3]	99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3]	X43	Xx X: 43 X: (2-)24-37
606-149-00-3	xxxxxxxxxx (XXX); 2-{2-xxxxx-4-(xxxxxxxxxxxxxx)-3-[(2,2,2-xxxxxxxxxxxxxx)xxxxxx]xxxxxxx}xxxxxxxxxx-1,3-xxxx		335104-84-2	Xxxx. Xxx. 3; X63 Xx; X48/22 X43 X; X50-53	Xx; X X: 43-48/22-50/53-63 X: (2-)36/37-46-60-61	X; X50-53: X ≥ 0,25 % X; X51-53: 0,025 % ≤ C &xx;&xxxx;0,25 % X52-53: 0,0025 % ≤ X &xx;&xxxx;0,025 %
607-707-00-9	xxxxxxxxxx-X-xxxxx (XXX); xxxxx-(2X)-2-{4-[(6-xxxxx-1,3-xxxxxxxxxx-2-xx)xxx]xxxxxx}xxxxxxxxx	—	71283-80-2	Xx; X48/22 X43 X; X50-53	Xx; X X: 43-48/22-50/53 S: (2-)24-37-46-60-61	N; X50-53: C ≥&xxxx;25 % X; R51-53: 2,5 % ≤ C &xx;&xxxx;25 % X52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %
607-708-00-4	oktanová xxxxxxxx	204-677-5	124-07-2	X; X34 X; X51-53	X; X X: 34-51/53 X: (1/2-)26-36/37/39-45-61
607-709-00-X	xxxxxxxx xxxxxxxx	206-376-4	334-48-5	Xx; X36/38 X; R51-53	Xi; X X: 36/38-51/53 X: (2-)25-46-61
607-710-00-5	1,2-xxxxxxxxxxxxxxxxxxx kyselina, xxxxxxxxxxxx, rozvětvený a lineární	271-093-5	68515-50-4	Repr. Xxx. 2; X60-61	X X: 60-61 X: 53-45
607-711-00-0	xxxxxxxxxxxxx (XXX); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx	—	203313-25-1	Xxxx. Xxx. 3; X62-63 Xx; R36/37 R43 N; R50-53	Xn; X X: 36/37-43-50/53-62-63 S: (2-)36/37-60-61	Xi; X43: C ≥ 0,1 % X; X50-53: X ≥&xxxx;25 % X; X51-53: 2,5 % ≤ X &xx;&xxxx;25 % X52-53: 0,25 % ≤ X < 2,5 %
607-712-00-6	xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx	250-778-2	31717-87-0	Xxxx. Xxx. 3; X63 X; R34 R43 N; X51-53	X; X X: 34-43-51/53-63 X: (1/2-)26-28-36/37/39-45-61	X; X34: X ≥&xxxx;10 % Xx: R36/37/38: 5 % ≤ C &xx;&xxxx;10 %
607-713-00-1	fenpyroximát (XXX); xxxx-xxxxx-4-[({(X)-[(1,3-xxxxxxxx-5-xxxxxx-1X-xxxxxxx-4-xx)xxxxxxxx]xxxxx}xxx)xxxxxx]xxxxxxx	—	134098-61-6	X+; X26 Xx; R22 R43 N; X50-53	X+; X X: 22-26-43-50/53 X: (1/2-)28-36/37-45-60-61-63	X; R50-53: C ≥&xxxx;0,25 % N; X51-53: 0,025 % ≤ X &xx;&xxxx;0,25 % X52-53: 0,0025 % ≤ X < 0,025 %
607-714-00-7	xxxxxxxxxxxxxx-xxxxxx; xxxxxx-2-({[4-(xxxxxxxxxxxxx)-6-(2,2,2-xxxxxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxx}xxxxxxxxx)-3-xxxxxxxxxxxxx	—	126535-15-7	Xxxx. Xxx. 3; X40 X; R50-53	Xn; X X: 40-50/53 X: (2-)36/37-60-61	N; R50-53: X ≥&xxxx;0,25 % X; X51-53: 0,025 % ≤ C < 0,25 % X52-53: 0,0025 % ≤ X < 0,025 %
607-715-00-2	xxxxxxxxx (XXX); isopropyl-2-(4-methoxybifenyl-3-yl)hydrazinkarboxylát	442-820-5	149877-41-8	R43 N; X50-53	Xx; N R: 43-50/53 X: (2-)24-37-60-61	X; X50-53: X ≥&xxxx;25 % X; X51-53: 2,5 % ≤ X &xx;&xxxx;25 % X52-53: 0,25 % ≤ X < 2,5 %
613-319-00-0	xxxxxxxx	206-019-2	288-32-4	Xxxx. Xxx 2; X61 Xx; X22 X; X34	X; X X: 22-34-61 X: 53-45
613-320-00-6	lenacil (ISO); 3-xxxxxxxxxx-6,7-xxxxxxx-1X-xxxxxxxxxx[x]xxxxxxxxx-2,4(3X,5X)-xxxx	218-499-0	2164-08-1	Xxxx. Cat. 3; X40 X; X50-53	Xx; X X: 40-50/53 X: (2-)36/37-60-61	X; X50-53: X ≥&xxxx;2,5 % X; X51-53: 0,25 % ≤ C &xx;&xxxx;2,5 % X52-53: 0,025 % ≤ C &xx;&xxxx;0,25 %
616-213-00-2	xxxxxxxxxxxxx (ISO); 2-(4-xxxxxxxxxx)-X-{2-[3-xxxxxxx-4-(xxxx-2-xx-1-xxxxx)xxxxx]xxxxx}-2-(xxxx-2-xx-1-xxxxx)xxxxxxxx	—	374726-62-2	X; X50-53	X X: 50/53 X: 60-61	N; X50-53: C ≥ 25 % X; R51-53: 2,5 % ≤ C &xx;&xxxx;25 % R52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %
616-214-00-8	xxxxxxxxx (ISO); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx	—	139528-85-1	Xxxx. Cat. 3; X40 Xx; X48/22 X; R50-53	Xn; X X: 40-48/22-50/53 X: (2-)36/37-46-60-61	X; X50-53: X ≥&xxxx;0,025 % X; X51-53: 0,0025 % ≤ C &xx;&xxxx;0,025 % X52/53: 0,00025 % ≤ X &xx;&xxxx;0,0025 %
616-215-00-3	xxxxxxxxxxxx-X (ISO); 2-xxxxx-X-(2,4-xxxxxxxx-3-xxxxxxx)-X-[(2X)-1-xxxxxxxxxxxxx-2-xx]xxxxxxxx	—	163515-14-8	Xx; X22 X43 X; X50-53	Xx; X X: 22-43-50/53 X: (2-)24-37-60-61	X; X50-53: X ≥&xxxx;2,5 % X; R51-53: 0,25 % ≤ C &xx;&xxxx;2,5 % X52-53: 0,025 % ≤ X &xx;&xxxx;0,25 %
616-216-00-9	xxxxxxxxxx (ISO); X-(xxxxxxxxxxx)-4-(xxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx	—	158062-67-0	Xx; X22	Xx X: 22 X: (2-)46
616-217-00-4	xxxxxxxxxxx (XXX); [methyl(oxo){1-[6-(trifluormethyl)-3-pyridyl]ethyl}-λ6-sulfanyliden]kyanamid	—	946578-00-3	Xn; X22 X; X50-53	Xx; N R: 22-50/53 X: (2-)60-61	N; X50-53: X ≥ 25 % X; X51-53: 2,5 % ≤ X &xx;&xxxx;25 % X52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

Plné znění - 32015R1221

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32015R1221

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.